Tango Therapeutics (TNGX) Other Gross PP&E Adjustments (2020 - 2025)
Tango Therapeutics has reported Other Gross PP&E Adjustments over the past 6 years, most recently at -$18.2 million for Q4 2025.
- Quarterly results put Other Gross PP&E Adjustments at -$18.2 million for Q4 2025, up 20.91% from a year ago — trailing twelve months through Dec 2025 was -$18.2 million (up 20.91% YoY), and the annual figure for FY2025 was -$18.2 million, up 20.91%.
- Other Gross PP&E Adjustments for Q4 2025 was -$18.2 million at Tango Therapeutics, up from -$19.2 million in the prior quarter.
- Over the last five years, Other Gross PP&E Adjustments for TNGX hit a ceiling of $11.0 million in Q2 2022 and a floor of -$33.3 million in Q3 2022.
- Median Other Gross PP&E Adjustments over the past 5 years was -$23.6 million (2024), compared with a mean of -$18.6 million.
- Biggest five-year swings in Other Gross PP&E Adjustments: soared 404.7% in 2021 and later crashed 11492.81% in 2022.
- Tango Therapeutics' Other Gross PP&E Adjustments stood at $6.1 million in 2021, then crashed by 629.47% to -$32.3 million in 2022, then increased by 14.61% to -$27.6 million in 2023, then grew by 16.57% to -$23.0 million in 2024, then grew by 20.91% to -$18.2 million in 2025.
- The last three reported values for Other Gross PP&E Adjustments were -$18.2 million (Q4 2025), -$19.2 million (Q3 2025), and -$20.2 million (Q2 2025) per Business Quant data.